Opioids and differentiation in human cancer cells.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Neuropeptides

• Publication date

  2005-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.NPEP.2005.07.001PMID 16169076
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Opioid growth factor inhibition of a human squamous cell carcinoma of the head and neck in nude mice: dependency on the route of administration.

  2004cited by this paper
• Cytoskeletal Genes Regulation by Chronic Morphine Treatment in Rat Striatum

  2004cited by this paper
• Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas

  2004cited by this paper
• Microtubules as a target for anticancer drugs

  2004cited by this paper
• Class III beta-tubulin in human development and cancer.

  2003cited by this paper
• Class III β-tubulin in human development and cancer†

  2003cited by this paper
• Mu‐ and delta‐opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors

  2003cited by this paper
• Opioids and the apoptotic pathway in human cancer cells.

  2003cited by this paper
• [Effect of opioid peptides on proliferation and differentiation of skeletogenic cells of rabbit bone marrow in vitro].

  2002cited by this paper
• Assay-based quantitative analysis of PC12 cell differentiation.

  2002cited by this paper
• Effect of opioid peptides on proliferation and differentiation of skeletogenic cells of rabbit bone marrow in vitro

  2002cited by this paper
• The biology of the opioid growth factor receptor (OGFr).

  2002cited by this paper
• The influence of different sub-type delta opioid receptors in nerve growth factor-induced neuronal differentiation in rat pheochromocytoma PC12 cell.

  2001cited by this paper
• Identification and characterization of opioid growth factor receptor in human pancreatic adenocarcinoma.

  2000cited by this paper
• Opioid growth factor regulates the cell cycle of human neoplasias.

  2000cited by this paper
• Reepithelialization of the human cornea is regulated by endogenous opioids.

  2000cited by this paper
• The opioid growth factor receptor in human head and neck squamous cell carcinoma.

  2000cited by this paper
• Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of μ and δ receptor activation on proliferation and neurite elongation

  2000cited by this paper
• Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor.

  1999cited by this paper
• Human neuroblastoma cell growth in tissue culture is regulated by opioid growth factor.

  1999cited by this paper
• Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor.

  1999cited by this paper
• Opioid agonists modify breast cancer cell proliferation by blocking cells to the G2/M phase of the cycle: Involvement of cytoskeletal elements

  1999cited by this paper
• Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor.

  1999cited by this paper
• Opioid growth factor and organ development in rat and human embryos.

  1999cited by this paper
• β-Casomorphin-5 stimulates neurite outgrowth in a mouse neuroblastoma cell line (Neuro-2a)

  1998cited by this paper
• The negative influence of endogenous opioid receptor activity on the differentiation of the rat pheochromocytoma PC12 cells induced by nerve growth factor.

  1998cited by this paper
• Opioid Growth Factor, [Met5]-Enkephalin, and the Etiology, Pathogenesis, and Treatment of Gastrointestinal Cancer

  1998cited by this paper
• Early alterations of actin cytoskeleton in OK cells by opioids

  1998cited by this paper
• Cytokines : Stress and Immunity

  1998cited by this paper
• μ‐Opioids activate tyrosine kinase focal adhesion kinase and regulate cortical cytoskeleton proteins cortactin and vinculin in chick embryonic neurons

  1997cited by this paper
• Enkephalins modulate differentiation of normal human keratinocytes in vitro

  1997cited by this paper
• Taxol inhibits opioid binding on T47D human breast cancer cells.

  1997cited by this paper
• Opioid growth factor tonically inhibits human colon cancer cell proliferation in tissue culture.

  1996cited by this paper
• High opioid doses inhibit whereas low doses enhance neuritogenesis in PC12 cells.

  1996cited by this paper
• Enhancement of murine bone marrow macrophage differentiation by beta-endorphin.

  1995cited by this paper
• Morphine inhibits Purkinje cell survival and dendritic differentiation in organotypic cultures of the mouse cerebellum.

  1994cited by this paper
• Opiates selectively increase intracellular calcium in developing type-1 astrocytes: role of calcium in morphine-induced morphologic differentiation.

  1993cited by this paper
• Growth factors and hormones

  1993cited by this paper
• Opioid Growth Factor Receptor in the Developing Nervous System

  1993cited by this paper
• Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.

  1993cited by this paper
• Chronic naltrexone treatment increases expression of preproenkephalin and preprotachykinin mRNA in discrete brain regions

  1990cited by this paper
• Endogenous opioid systems and the regulation of dendritic growth and spine formation

  1989cited by this paper
• Combinative ligand‐receptor interactions: Effects of CAMP, epinephrine, and met‐enkephalin on RAW264 macrophage morphology, spreading, adherence, and microfilaments

  1989cited by this paper
• Endogenous opioid systems and neural cancer: transmission and scanning electron microscopic studies of murine neuroblastoma in tissue culture.

  1988cited by this paper
• Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment.

  1988cited by this paper
• A human neuroblastoma cell line expresses mu and delta opioid receptor sites.

  1986cited by this paper
• Involucrin and other markers of keratinocyte terminal differentiation.

  1983cited by this paper
• Human squamous cell carcinoma. Establishment and characterization of new permanent cell lines.

  1981cited by this paper
• Tumor promoters inhibit morphological differentiation in cultured mouse neuroblastoma cells.

  1978cited by this paper
• The Pharmacological Basis of Therapeutics

  1976cited by this paper
• Glia-induced morphological differentiation in neuroblastoma cells.

  1973cited by this paper
• Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture.

  1973cited by this paper
• 5-bromodeoxyuridine-induced differentiation of a neuroblastoma.

  1970cited by this paper

• The Opioid Growth Factor in Growth Regulation and Immune Responses in Cancer.

  2024cites this paper
• Effect of Opioid Receptor Activation and Blockage on the Progression and Response to Treatment of Head and Neck Squamous Cell Carcinoma

  2023cites this paper
• Involvement of the Opioid Peptide Family in Cancer Progression

  2023cites this paper
• The µ‐Opioid Receptor in Cancer and Its Role in Perineural Invasion: A Short Review and New Evidence

  2022cites this paper
• Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu‐opioid receptor

  2021cites this paper
• Preclinical and clinical studies into the bioactivity of low-dose naltrexone (LDN) for oncotherapy.

  2021cites this paper
• Avaliação dos biomarcadores imunológicos (razão de celulas t CD4+/CD8+ e EXPRESSÃO de MHC I por monócitos) em cadelas com carcinomas mamários

  2020cites this paper
• The effect of naltrexone as a carboplatin chemotherapy-associated drug on the immune response, quality of life and survival of dogs with mammary carcinoma

  2018cites this paper
• Neuron-restrictive silencer factor–mediated downregulation of μ-opioid receptor contributes to the reduced morphine analgesia in bone cancer pain

  2017cites this paper
• Topical Loperamide-Encapsulated Liposomal Gel Increases the Severity of Inflammation and Accelerates Disease Progression in the Adjuvant-Induced Model of Experimental Rheumatoid Arthritis

  2017cites this paper
• Methionine enkephalin, its role in immunoregulation and cancer therapy.

  2016cites this paper
• Evaluation of therapeutic effect of low dose naltrexone in experimentally-induced Crohn's disease in rats.

  2016cites this paper
• Expressions of matrix metalloproteinases-1 and -9 and opioid growth factor in rabbit cornea after lamellar keratectomy and treatment with 1% nalbuphine.

  2015cites this paper
• Opioid growth factor and the treatment of human pancreatic cancer: a review.

  2014cites this paper
• Serum CD10 is associated with liver metastasis in colorectal cancer.

  2014cites this paper
• Proenkephalin-Derived Peptides

  2013cites this paper
• Expressão da metaloprotease-1, da metaloprotease-9 e do fator de crescimento opióide em córneas de coelhos tratadas com nalbufina a 1%, após ceratectomia lamelar

  2012cites this paper
• Modulation of the opioid growth factor ([Met5]‐enkephalin)–opioid growth factor receptor axis: Novel therapies for squamous cell carcinoma of the head and neck

  2012cites this paper
• Methionine enkephalin (MENK) improved the functions of bone marrow-derived dendritic cells (BMDCs) loaded with antigen

  2012cites this paper
• The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and its implications for health and disease.

  2012cites this paper
• Therapy with the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn’s Disease: A Randomized Placebo-Controlled Trial

  2011cites this paper
• T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.

  2011cites this paper
• B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases.

  2011cites this paper
• Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.

  2010cites this paper
• Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors

  2010cites this paper
• Opioid modulation of cell proliferation in the ventricular zone of adult zebra finches (Taenopygia guttata)

  2010cites this paper
• Study of Immunotherapy with Endogenous Opiod (Met-Enkephalin) Activated Tumor Infiltrating Lymphocytes in Fibrosarcoma Induced Balb/C Mice

  2010cites this paper
• Assistant Clerk to the Public Petitions Committee Parliament of Scotland , UK TG . 01 Edinburgh January 8 , 2010

  2010cites this paper
• Dynorphin expression, processing and receptors in the alveolar macrophages, cancer cells and bronchial epithelium of lung cancer patients.

  2010cites this paper
• The Influence of Opioids on Urokinase Plasminogen Activator on Protein and mRNA Level in MCF‐7 Breast Cancer Cell Line

  2009cites this paper
• Endogenous opioids and multiple sclerosis

  2009cites this paper
• Opioid growth factor-opioid growth factor receptor axis is a physiological determinant of cell proliferation in diverse human cancers.

  2009cites this paper
• Rotaxane-based propeptides: protection and enzymatic release of a bioactive pentapeptide.

  2009cites this paper
• Chapter 3 Micropatterning of cell attachment on pSi films by direct laser writing

  2009cites this paper
• The OGF-OGFr axis utilizes the p16INK4a and p21WAF1/CIP1 pathways to restrict normal cell proliferation.

  2009cites this paper
• Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells.

  2009cites this paper
• Asymmetric anodisation of silicon for biological and photonic applications

  2009cites this paper
• CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver

  2009cites this paper
• The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer

  2008cites this paper
• The Opioid Antagonist Naltrexone Improves Murine Inflammatory Bowel Disease

  2008cites this paper
• Expression of Opioid Growth Factor (OGF)–OGF Receptor (OGFr) Axis in Human Nonmedullary Thyroid Cancer

  2008cites this paper
• Imiquimod Upregulates the Opioid Growth Factor Receptor to Inhibit Cell Proliferation Independent of Immune Function

  2008cites this paper
• Using continuous porous silicon gradients to study the influence of surface topography on the behaviour of neuroblastoma cells.

  2008cites this paper
• Micropatterning of Porous Silicon Films by Direct Laser Writing

  2008cites this paper
• Prevention and delay in progression of human squamous cell carcinoma of the head and neck in nude mice by stable overexpression of the opioid growth factor receptor.

  2008cites this paper
• Prevention and delay in progression of human pancreatic cancer by stable overexpression of the opioid growth factor receptor.

  2008cites this paper
• Imaging δ- and μ-Opioid Receptors by PET in Lung Carcinoma Patients

  2007cites this paper
• Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells.

  2007cites this paper
• Imaging d - and m -Opioid Receptors by PET in Lung Carcinoma Patients

  2007cites this paper
• Morphine treatment accelerates sarcoma‐induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer

  2007cites this paper
• Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells.

  2007cites this paper
• Opioid-induced Hyperalgesia: Underlying Mechanisms and Clinical Relevance

  2007cites this paper
• Low-Dose Naltrexone Therapy Improves Active Crohn's Disease

  2007cites this paper
• Overexpression of the opioid growth factor receptor downregulates cell proliferation of human squamous carcinoma cells of the head and neck.

  2007cites this paper
• Imaging delta- and mu-opioid receptors by PET in lung carcinoma patients.

  2007cites this paper
• Proenkephalin-Derived Opioid Peptides

  2006cites this paper
• Progression of squamous cell carcinoma of the head and neck is associated with down-regulation of the opioid growth factor receptor.

  2006cites this paper
• Sympathetic nervous system and neurotransmitters: their possible role in neuroimmunomodulation of multiple sclerosis and some other autoimmune diseases

  2006cites this paper
• Endogenous opiates and behavior: 2005.

  2006cites this paper
• Opioid growth factor receptor is unaltered with the progression of human pancreatic and colon cancers.

  2006cites this paper
• methionine-enkephalin in the liver by abrogating the anti-tumoural effect of CD 10 enhances metastasis of colorectal cancer

  year unknowncites this paper